Wound Management News

The addition of adhesive strips did significantly improve the appearance of scars in wounds treated with buried interrupted subcuticular suturing, according to the results of a recently published study.

U.S. Marshals seized unapproved prescription drug products valued at more than $1.5 million from Stratus Pharmaceuticals in Miami, according to a press release from the FDA.

Results from a multicenter, prospective, randomized double blind clinical trial indicate clindamycin and trimethoprim-sulfamethoxazole have comparable efficacy and safety for treatment of uncomplicated skin infections.

Healio.com/Dermatology will provide coverage of the American Academy of Dermatology Annual Meeting in San Francisco beginning Friday.

BMG Pharma announced it has launched its proprietary Ialuxid gel in the People’s Republic of China for the treatment of post-surgical wounds.

Patients treated with carbon dioxide laser evaporation for hidradenitis suppurativa reported satisfaction with the procedure despite a more than 29% recurrence rate of lesions, according to study results.

Recent FDA developments related to dermatology included the agency granting priority review to cobimetinib combined with Zelboraf for advanced melanoma.

While it is certain that health care-associated methicillin-resistant Staphylococcus aureus infections lead to increased mortality, length of hospital stay and costs, the evidence is mixed regarding standard procedures to prevent and control MRSA infections that occur in the health care setting.   

Actavis announced that the FDA has accepted a supplemental new drug application for the label expansion of Teflaro for the treatment of concurrent bacteremia in patients with acute bacterial skin and skin structure infections caused by susceptible isolates of Staphyloccus aureus.

Based on the results of a chart review, researchers determined mild perioperative hypothermia appeared to be unrelated to wound complications.